Literature DB >> 8779832

Developmental regulation of cytochrome oxidase subunit VIa isoforms in cardiac and skeletal muscle.

W J Parsons1, R S Williams, J M Shelton, Y Luo, D J Kessler, J A Richardson.   

Abstract

Physiological requirements for mitochondrial respiration change during fetal and postnatal development of cardiac and skeletal muscle, particularly after the abrupt transition from the hypoxic fetal environment to the oxygen-rich milieu of the neonate. This study defines the pattern of expression of nuclear genes encoding the muscle-specific (H) and non-muscle-specific (L) isoforms of cytochrome oxidase (COX) subunit VIa during pre- and postnatal development of striated muscles in the mouse. In the early embryo, COX VIa-L was the predominant isoform expressed in all tissues. COX VIa-H mRNA was detectable as early as day 8 postcoitum (pc) in the heart, but not until gestational day 14 in skeletal myofibers of the tongue, diaphragm, and other skeletal muscles. At late fetal stages up until birth (days 16-18 pc), COX VIa-L and COX VIa-H were both expressed in striated myocytes, although the L form remained the dominant isoform. In postnatal animals, however, expression of COX VIa-H increased whereas COX VIa-L decreased in a reciprocal manner. Activation of the COX VIa-H gene also was observed during differentiation of nurine myogenic cells in culture and was followed by diminished expression of the COX VIa-L isoform in maturing myotubes, as in the intact animal. We conclude that regulation of nuclear genes encoding subunits of COX is a component of the developmental programs that govern cardiac and skeletal muscle differentiation and maturation in the mammalian fetus and neonate. COX VIa-L, the predominant isoform in all fetal tissues, is gradually replaced by the muscle-specific H isoform in both cardiac and skeletal muscles, although this transition is not complete until after birth.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8779832     DOI: 10.1152/ajpheart.1996.270.2.H567

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  7 in total

Review 1.  Mitochondrial Diseases Part I: mouse models of OXPHOS deficiencies caused by defects in respiratory complex subunits or assembly factors.

Authors:  Alessandra Torraco; Susana Peralta; Luisa Iommarini; Francisca Diaz
Journal:  Mitochondrion       Date:  2015-02-04       Impact factor: 4.160

2.  The gene encoding the heart/muscle isoform of cytochrome c oxidase subunit VIII maps to mouse chromosome 7.

Authors:  G J Makris; M I Lomax
Journal:  Mamm Genome       Date:  1997-06       Impact factor: 2.957

3.  Subunit change in cytochrome c oxidase: identification of the oxygen switch in Dictyostelium.

Authors:  R Bisson; S Vettore; E Aratri; D Sandona
Journal:  EMBO J       Date:  1997-02-17       Impact factor: 11.598

Review 4.  Regulation of energy transduction and electron transfer in cytochrome c oxidase by adenine nucleotides.

Authors:  B Kadenbach; J Napiwotzki; V Frank; S Arnold; S Exner; M Hüttemann
Journal:  J Bioenerg Biomembr       Date:  1998-02       Impact factor: 2.945

Review 5.  Mouse models of oxidative phosphorylation defects: powerful tools to study the pathobiology of mitochondrial diseases.

Authors:  Alessandra Torraco; Francisca Diaz; Uma D Vempati; Carlos T Moraes
Journal:  Biochim Biophys Acta       Date:  2008-06-13

6.  Nuclear respiratory factor 1 controls myocyte enhancer factor 2A transcription to provide a mechanism for coordinate expression of respiratory chain subunits.

Authors:  Bindu Ramachandran; Gengsheng Yu; Tod Gulick
Journal:  J Biol Chem       Date:  2008-01-24       Impact factor: 5.157

7.  Unraveling the molecular signatures of oxidative phosphorylation to cope with the nutritionally changing metabolic capabilities of liver and muscle tissues in farmed fish.

Authors:  Azucena Bermejo-Nogales; Josep Alvar Calduch-Giner; Jaume Pérez-Sánchez
Journal:  PLoS One       Date:  2015-04-15       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.